Insuring rapid and robust safety assessment [10]

Journal of Investigative Dermatology

Volumn 122, Issue 3, 2004, Pages 857-858

  Stern, Robert S ^a   Njisten, Tamar ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

CANCER RISK; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG INDUSTRY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; HUMAN; INTERVIEW; LETTER; MEDICAL DECISION MAKING; MEDICAL RESEARCH; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSORIASIS; PUBLICATION; PUVA; RADIATION DOSE; RADIATION EXPOSURE; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

EID: 1842740021     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22345.x     Document Type: Letter

References (13)

1. Als-Nielsen B, Chen W, Gluud C, Kjaergard L: Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events. JAMA 290:921-928, 2003
2. Center for Drug Evaluation and Research: Postmarketing commitments, 2003a. http://www.fda.gov/cber/fdama/pstmrktfdama130.htm
3. Center for Drug Evaluation and Research: Postmarketing commitments, 2003b. http://www.fda.gov/cber/fdama/pstmrktfdama130.pdf
4. Ellis CN, Gorsulowky DC, Hamilton TA, et al: Cyclosporin improves psoriasis in a double-blind study. JAMA 256:3110-3116, 1986
5. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL: Oral methoxsalen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J Invest Dermatol 68:328-335, 1977
6. Mueller W, Herrman B: Cyclosporin A for psoriasis. N Engl J Med 301:555, 1979
7. Njisten T, Stern R: The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: A cohort study. J Invest Dermatol 121:252-258, 2003
8. Paul CF: Treating severe psoriasis: How to navigate safety between Scylla and Charybdis? J Invest Dermatol 121:ix-x, 2003
9. Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillame JC, Lamarque V, Dubertret L: Risk of malignancies in psoriasis patients treated with cyclosporine: A 5 y cohort study. J Invest Dermatol 120:211-216, 2003
10. Rennie D: Thyroid storm. JAMA 277:1238-1243, 1997
11. Stern RS, Thibodeau LA, Parrish JA, Fitzpatrick TB: Skin cancer after PUVA treatment for psoriasis. N Engl J Med 301:555, 1979
12. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL: Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 310:1156-1161, 1984
13. Stern RS: Assessing the safety of immunologic modifiers for the treatment of chronic disease: The psoriasis paradigm. J Invest Dermatol 120:xi-xii, 2003